Search results
Vir Biotechnology (VIR) Up on Positive Data From HDV Study
Zacks via Yahoo Finance· 13 hours agoVir Biotechnology (VIR) rises on upbeat data from its phase II study evaluating tobevibart and...
iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Scotia Capital Inc.
ETF DAILY NEWS· 4 days agoScotia Capital Inc. lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 6.7% during the 4th quarter, according to its most recent 13F filing with ...
Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?
Benzinga via Yahoo Finance· 1 day agoOn Wednesday, Vir Biotechnology Inc (NASDAQ:VIR) announced new preliminary data from its Phase 2...
GSK acquires oligonucleotide drug startup Elsie
BioPharma Dive via Yahoo Finance· 14 hours ago“We have already made great strides in oligonucleotide drug development through our work in chronic hepatitis B and steatotic liver disease, and are...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 hours agoRapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients ...
MAIA Biotechnology reports promising Phase 2 trial results By Investing.com
Investing.com· 3 days agoMAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company, has...
Rathbones Group PLC Acquires 10,000 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)
ETF DAILY NEWS· 3 days agoRathbones Group PLC lifted its stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 45.3% in the fourth quarter, according to its most recent Form 13F filing with ...
Steward Partners Investment Advisory LLC Cuts Stock Holdings in iShares Biotechnology ETF...
ETF DAILY NEWS· 7 days agoSteward Partners Investment Advisory LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 5.0% during the 4th quarter, according to the company ...
Why Is Virax Biolabs (VRAX) Stock Up 115% Today?
InvestorPlace· 18 hours agoVirax Biolabs (NASDAQ:VRAX) stock is rocketing higher on Thursday morning alongside heavy pre-market trading of the biotechnology company’s shares. The...
Vir stock gains on hepatitis drug data (NASDAQ:VIR)
Seeking Alpha· 2 days agoVir Biotechnology (VIR) stock gains as its hepatitis therapy tobevibart developed with Xencor shows early signs of efficacy in a Phase 2 trial. Read more...
